Effects of RU 486 on energy expenditure and meal tolerance in normal men.

Journal of the American College of Nutrition

Volumn 15, Issue 3, 1996, Pages 283-288

  Jobin, Nathalie ^a   de Jonge, Lilian ^a   Garrel, Dominique R ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; INSULIN; LIPID; MIFEPRISTONE; NITROGEN; PROTEIN; TRANSCORTIN;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY EXPENDITURE; GAS EXCHANGE; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MEAL; METABOLIC RATE; ORAL DRUG ADMINISTRATION; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; ANIMALS; BLOOD GLUCOSE; CREATININE; DOUBLE-BLIND METHOD; ENERGY METABOLISM; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; HUMANS; HYDROCORTISONE; INSULIN; MALE; MIFEPRISTONE; NITROGEN; RATS; TIME FACTORS;

EID: 0029941847     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1996.10718599     Document Type: Article

References (30)

1. Walker BR, Edwards CRW: Cushing's syndrome. In lames VHT (ed): ''The adrenal gland," 2nd edition. New York: Raven Press, Ltd., pp. 289-318, 1992.
2. Bray GA, Fisler I, York DA: Neuroendocrine control of the development of obesity: understanding gained from studies of experimental animal model; Frontiers in Neuroendocrinology 11:128-181, 1990.
3. Holt S, York DA, Fitzsimons ITR: The effects of corticosterone, cold exposure and overfeeding with sucrose on brown adipose tissue of obese Zucker rats (fa/fa). Biochem J 214:215-223, 1983.
4. Shargill NS, Lupien JR, Bray GA: Adrenalectomy in genetically obese ob/ob and db/db mice increases the proton conductance pathway. Horm Metabol Res 21:463--467, 1989.
5. Walker HC, Romsos DR: Glucocorticoids in the CNS regulate BAT metabolism and plasma insulin in ob/ob mice. Am 1 Physiol 262:E11Q-E117, 1992.
6. Bruce BK, King BM, Phelps GR, Veitia MC: Effects of adrenalectomy and corticosterone administration on hypothalamic obesity in rats. Am 1 Physiol 243:EI52-EI57, 1982.
7. Debons AF, Zurek LD, Tse CS, Abrahamsen S: Central nervous system control of hyperphagia in hypothalamic obesity: Dependence on adrenal glucocorticoids. Endocrinology 118(4): 1678-1681, 1986.
8. Macchington D, Rothwell NJ, Stock MI, York DA: Thermogenesis and sympathetic activity in BAT of overfed rats after adrenalectomy. Am J Physiol 250:E362-366, 1986.
9. Baulieu EE: The steroid antagonist RUEndocrinol Metab Clin North Am 20(4):873-891, 1991.
10. Kawai M, Lynette KN, Brandon DD, Udelsman R, Loriau DL, Chrouses GP: Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU486 in man. J Pharmacol Exper Ther 241(2):401--406, 1987.
11. Philibert D, Deraedt R, Teutsch G: RU 38486: A potent antiglucocorticoid in vivo. (Abstract no. 1463). Adv Pharmacol Ther Proc Int Congr 8th, 1981.
12. Philibert D: RU 38486: An original multifaced antihormone in vivo. In Agarwal MK (ed): –Adrenal Steroid Antagonism.— New York: de Gruyter, pp 77-101, 1984.
13. Kawai S, Nieman LK, Brandon DD, Udelsman R, Loriaux DL, Chrouso P: Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man. J Phacm Exp. Ther 241 (2): 401--406, 1987.
14. Garrel DR, Moussali R, Lesiege D, Lariviere F: RU486 prevents the acute effect of cortisol on leucine and glucose metabolism. J Clin Endocrinol Metab 80:379-385, 1995.
15. Okada S, York DA, Bray GA: Mifepristone (RU486), a blocker of type IT glucocorticoid and progestin receptors, reverses a dietary form of obesity. Am J Physiol 262:RII06--IO, 1992.
16. Hardwick AI, Linton EA, Rothwell NJ: Thermogenic effects of the antiglucocorticoid RU486 in the rat: Involvement of corticotropinreleasing-factor and sympathetic activation of brown adipose tissue. Endocrinology 124(4):1684-1688, 1989.
17. Garrel DR, De Jonge L: Intragastric versus oral feeding: effect on the thermogenic response to feeding in lean and obese subjects. Am J Clin Nutr 59:971-974, 1994.
18. Houde-Nadeau M, De Jonge L, Garrel DR: Thermogenic response to food: intra-individual variability and measurement reliability. J Am Coli Nutr 12(5):511-516, 1993.
19. Piers LS, Soares MI, Makran T, Shetty PS: Thermic effect of a meal. I. Methodology and variations in normal young adults. Br J Nutr 67:165-175, 1992.
20. 288 Hammond GL, Nisker JA, Jones LA, Siiteri PK: Estimation of the percentage of the free steroid in undiluted serum by centrifugal ultracentrifugation-dialysis. J Bioi Chern 255:5023-5026, 1980.
21. Hammond GL, Lahteenmaki PLA: A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin Chim Acta 132:101-110, 1983.
22. Weir JB: New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol I09:1-9, 1949.
23. Arase K, Shargill NS, Bray GA: Effects of corticotropin-releasingfactor on genetically obese (fatty) rats. Physiol Behavior 45(3): 565-570, 1989.
24. Van Cauter E, Shapiro ET, Tillil H, Polonsky S: Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am J Physiol 262:E467-E475, 1992.
25. Marin P, Darin N, Ameniya T, Anderson B, Jem S, Bjomtop P: Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41(8):882-886, 1992.
26. Perkoff G, Paraker V, Mccall J, Tyler F: Early effect of cortisol on glucose metabolism in man. J Lab Clin Med 62:431--436, 1963.
27. Rizza RA, Mandarino U, Gerich IE: Cortisol induces insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilisation due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 54: 131-138, 1982.
28. Bertagna X, Bertagna C, Luton JP, Husson IM, Girard F: The new steroid analogue RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab 59:25-28, 1984.
29. Gaillard RC, Riondel AM, Herman W, Muller AF, Baulieu EE: The antifertility steroid RU 486 Is an antiglucocorticoid depressing the pituitary adrenal system in the human, but only at a specific time during the day. Proc Natl Acad Sci USA 81:3879-3882,1984.
30. Simons SS: Structure-activity relationships of glucocorticoids: importance of the regulated gene and trans-acting factors in determining glucocorticoid and antiglucocorticoid activity. In Bohl M, Duax WL (eds): –Molecular Structure and Biological Activity of Steroids.— Boca Raton: CRC Press pp 259-292, 1992.